FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns an agent for inhibition of visceral fat uptake, for decrease in abdominal fat amount, and for prevention or reduction of visceral obesity that is considered as a principal factor of metabolic syndrome. There is presented agent or foodstuff, or drink containing 3-O-b-D-glucopyranosyl-4-methylergost-7-en-3-ole as a reacting component, extract in an organic solvent, extract in hot water, residual liquid of Liliaceae plant or its part which contains a compound.
EFFECT: agent possesses high clinical effectiveness with respect to visceral obesity.
6 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION FOR INHIBITION OF VISCERAL FATTY TISSUE ACCUMULATION | 2006 |
|
RU2419438C2 |
ANTIOXIDANT | 2009 |
|
RU2465909C1 |
PREPARATION TO REDUCE INSULIN RESISTANCE | 2006 |
|
RU2379037C2 |
GLYCOSIDE DERIVATIVE, METHOD FOR ITS PREPARING, COMPOSITION, AGENT FOR CORRECTION OF HYPERGLYCEMIA, MEDICINAL AGENT, FOODSTUFFS, METHOD FOR CORRECTION OF HYPERGLYCEMIA | 2005 |
|
RU2315770C1 |
ALOE VERA EXTRACT, METHOD OF PRODUCING ALOE VERA EXTRACT AND HYPERGLYCEMIA-REDUCING AGENT | 2006 |
|
RU2356572C1 |
AGENT FOR DECREASING INSULIN RESISTANCE | 2006 |
|
RU2380103C2 |
MEDICAL PRODUCT AND FOODSTUFF OR DRINK FOR IMPROVEMENT OF PANCREAS FUNCTIONS | 2006 |
|
RU2350346C1 |
MEDICINAL AGENT AND FOODSTUFF OR BEVERAGE FOR DECREASING HYPERGLYCEMIA | 2005 |
|
RU2315601C1 |
PREPARATION TO IMPROVE CONDITION IN INSULIN RESISTANCE | 2006 |
|
RU2379313C2 |
ANTIOXIDANT | 2009 |
|
RU2481116C2 |
Authors
Dates
2009-11-20—Published
2006-09-21—Filed